BackNeuberger Berman High Yield Strategies Fund Overview

Neuberger Berman High Yield Strategies Fund Operating Income

Track Neuberger Berman High Yield Strategies Fund's operating income ($42M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$6.67M
17.32% YoY

As of Apr 30, 2026

Annual Operating Income (TTM)

$41.85M
3.45% YoY

Trailing 12 months ending Apr 30, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Neuberger Berman High Yield Strategies Fund (NHS) FAQ

The latest operating income for NHS is $42M as of April 2026. That compares with $43M in the prior-year period — down 3.4% year over year. Investors often review this figure alongside Neuberger Berman High Yield Strategies Fund's historical trend and sector peers before judging valuation or financial health.

Over the past year, NHS's operating income moved from $43M to $42M — a 3.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Neuberger Berman High Yield Strategies Fund's operating scale or balance-sheet position.

A operating income figure of $42M for NHS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NHS's operating income ($42M), review year-over-year change from $43M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.